Gilles Vazeux

1.1k total citations
15 papers, 935 citations indexed

About

Gilles Vazeux is a scholar working on Oncology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Gilles Vazeux has authored 15 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Gilles Vazeux's work include Peptidase Inhibition and Analysis (10 papers), Neuropeptides and Animal Physiology (7 papers) and Chemical Synthesis and Analysis (5 papers). Gilles Vazeux is often cited by papers focused on Peptidase Inhibition and Analysis (10 papers), Neuropeptides and Animal Physiology (7 papers) and Chemical Synthesis and Analysis (5 papers). Gilles Vazeux collaborates with scholars based in France, Greece and French Guiana. Gilles Vazeux's co-authors include Pierre Corvol, Catherine Llorens‐Cortés, Xavier Iturrioz, Vincent Dive, Jöel Cotton, J Dausset, Iman Khalil‐Daher, Pascale Paul, Edgardo D. Carosella and Sophie Lefebvre and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Gilles Vazeux

15 papers receiving 924 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gilles Vazeux France 12 399 288 247 189 186 15 935
Georgia Floyd-Smith United States 15 594 1.5× 410 1.4× 235 1.0× 102 0.5× 22 0.1× 31 996
Carlos Reyes‐Moreno Canada 22 313 0.8× 325 1.1× 244 1.0× 10 0.1× 8 0.0× 44 1.2k
Howard A. Kaplan United States 14 715 1.8× 327 1.1× 49 0.2× 8 0.0× 22 0.1× 23 1.1k
Ann‐Muriel Steff Canada 17 545 1.4× 331 1.1× 164 0.7× 16 0.1× 45 0.2× 32 984
Andrew A. Branca United States 13 271 0.7× 546 1.9× 297 1.2× 24 0.1× 10 0.1× 17 906
Susan Fong United States 15 675 1.7× 270 0.9× 173 0.7× 16 0.1× 56 0.3× 19 1.2k
Corinne Rommens France 14 640 1.6× 157 0.5× 96 0.4× 106 0.6× 8 0.0× 28 1.0k
Gessica Filocamo Italy 11 837 2.1× 97 0.3× 244 1.0× 33 0.2× 40 0.2× 16 1.7k
Jay A. Haron United Kingdom 8 446 1.1× 125 0.4× 80 0.3× 28 0.1× 34 0.2× 13 708
Stephen Yanofsky United States 15 559 1.4× 235 0.8× 73 0.3× 9 0.0× 50 0.3× 17 873

Countries citing papers authored by Gilles Vazeux

Since Specialization
Citations

This map shows the geographic impact of Gilles Vazeux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilles Vazeux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilles Vazeux more than expected).

Fields of papers citing papers by Gilles Vazeux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilles Vazeux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilles Vazeux. The network helps show where Gilles Vazeux may publish in the future.

Co-authorship network of co-authors of Gilles Vazeux

This figure shows the co-authorship network connecting the top 25 collaborators of Gilles Vazeux. A scholar is included among the top collaborators of Gilles Vazeux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilles Vazeux. Gilles Vazeux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Cotton, Jöel, Mirian A.F. Hayashi, Philippe Cuniasse, et al.. (2002). Selective Inhibition of the C-Domain of Angiotensin I Converting Enzyme by Bradykinin Potentiating Peptides. Biochemistry. 41(19). 6065–6071. 76 indexed citations
2.
Junot, Christophe, Éric Ezan, Jöel Cotton, et al.. (2001). RXP 407, a Selective Inhibitor of the N-Domain of Angiotensin I-Converting Enzyme, Blocks in Vivo the Degradation of Hemoregulatory Peptide Acetyl-Ser-Asp-Lys-Pro with No Effect on Angiotensin I Hydrolysis. Journal of Pharmacology and Experimental Therapeutics. 297(2). 606–611. 77 indexed citations
3.
Paul, Pascale, El Chérif Ibrahim, Sophie Lefebvre, et al.. (2000). Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Human Immunology. 61(11). 1138–1149. 265 indexed citations
4.
Iturrioz, Xavier, Gilles Vazeux, Jérôme Célérier, Pierre Corvol, & Catherine Llorens‐Cortés. (2000). Histidine 450 Plays a Critical Role in Catalysis and, with Ca2+, Contributes to the Substrate Specificity of Aminopeptidase A. Biochemistry. 39(11). 3061–3068. 33 indexed citations
5.
Georgiadis, Dimitris, Gilles Vazeux, Catherine Llorens‐Cortés, Athanasios Yiotakis, & Vincent Dive. (2000). Potent and Selective Inhibition of Zinc Aminopeptidase A (EC 3.4.11.7, APA) by Glutamyl Aminophosphinic Peptides:  Importance of Glutamyl Aminophosphinic Residue in the P1 Position. Biochemistry. 39(5). 1152–1155. 23 indexed citations
6.
Iturrioz, Xavier, Gilles Vazeux, M.-C. Fournié-Zaluski, et al.. (2000). Aminopeptidase A, which generates one of the main effector peptides of the brain renin‒angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure. Biochemical Society Transactions. 28(4). 435–435. 20 indexed citations
7.
Iturrioz, Xavier, Gilles Vazeux, M C Fournié-Zaluski, et al.. (2000). Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure. Biochemical Society Transactions. 28(4). 435–440. 53 indexed citations
8.
Dive, Vincent, Jöel Cotton, Athanasios Yiotakis, et al.. (1999). RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites. Proceedings of the National Academy of Sciences. 96(8). 4330–4335. 146 indexed citations
9.
Vazeux, Gilles, Sherwin Wilk, Elizabeth Wilk, Pierre Corvol, & Catherine Llorens‐Cortés. (1998). Production and properties of a recombinant soluble form of aminopeptidase A. European Journal of Biochemistry. 254(3). 671–678. 10 indexed citations
10.
Vazeux, Gilles, Xavier Iturrioz, Pierre Corvol, & Catherine Llorens‐Cortés. (1998). A glutamate residue contributes to the exopeptidase specificity in aminopeptidase A. Biochemical Journal. 334(2). 407–413. 64 indexed citations
11.
Vazeux, Gilles, Xavier Iturrioz, Pierre Corvol, & Catherine Llorens‐Cortés. (1997). A tyrosine residue essential for catalytic activity in aminopeptidase A. Biochemical Journal. 327(3). 883–889. 49 indexed citations
12.
Vazeux, Gilles, Jiyang Wang, Pierre Corvol, & Catherine Llorens‐Cortés. (1996). Identification of Glutamate Residues Essential for Catalytic Activity and Zinc Coordination in Aminopeptidase A. Journal of Biological Chemistry. 271(15). 9069–9074. 88 indexed citations
13.
Tesson, Frédérique, Claude Ruffié, Patrı́cia Silva, et al.. (1993). Cell-associated and soluble phospholipases A2 increase during carrageenan and zymosan-induced pleurisy in rat. European Journal of Pharmacology Environmental Toxicology and Pharmacology. 248(1). 27–32. 3 indexed citations
14.
Fandeur, Thierry, Gilles Vazeux, & Odile Mercereau‐Puijalon. (1993). The virulent Saimiri-adapted Palo Alto strain of Plasmodium falciparum does not express the ring-infected erythrocyte surface antigen. Molecular and Biochemical Parasitology. 60(2). 241–248. 9 indexed citations
15.
Vazeux, Gilles, Cécile Le Scanf, & T Fandeur. (1993). The RESA-2 gene of Plasmodium falciparum is transcribed in several independent isolates. Infection and Immunity. 61(10). 4469–4472. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Georgia Floyd-Smith Breakdown of academic impact, for papers by Carlos Reyes‐Moreno Breakdown of academic impact, for papers by Howard A. Kaplan Breakdown of academic impact, for papers by Ann‐Muriel Steff Breakdown of academic impact, for papers by Andrew A. Branca Breakdown of academic impact, for papers by Susan Fong Breakdown of academic impact, for papers by Corinne Rommens Breakdown of academic impact, for papers by Gessica Filocamo Breakdown of academic impact, for papers by Jay A. Haron Breakdown of academic impact, for papers by Stephen Yanofsky
Rankless by CCL
2026